MAPK3 and ischemia: Increasing evidence suggests an emerging role of Erk-1/2 in supporting neuronal survival [20-22]; however, a study by Zhuang et al. identified activated Erk-1/2 as a proapoptotic factor under certain conditions such as ischemia-induced brain injury [23].